Secukinumab treated patients in the Australian clinical practice setting: HOPE study investigating the quality of life in patients with severe chronic plaque psoriasis after treatment

被引：0
|
作者：
Foley, P. [1 ]
Walsh, M. [2 ]
Mate, E. [2 ]
机构：
[1] Skin & Canc Fdn Inc, Carlton, Vic, Australia
[2] Novartis Pharmaceut Australia Pty Ltd, Macquarie Pk, NSW, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [41] Secukinumab treatment shows a neutral impact on the lipid profile of patients with moderate to severe plaque psoriasis in a dose-ranging study
    Philipp, Sandra
    Escrig, Cesar
    Papavassilis, Charis
    Thaci, Diamant
    Thurston, Helen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB213 - AB213
  • [42] Secukinumab Treatment of moderate to severe Plaque Psoriasis in the clinical Routine Care: Baseline Data from the PROSPECT Study on Psoriasis Pre-treatment
    von Kiedrowski, R.
    Korber, A.
    Kraehn-Senftleben, G.
    Sticherling, M.
    Lange, L.
    Bachhuber, T.
    Kasparek, T. R.
    Augustin, M.
    Thaci, D.
    Amon, U.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 138 - 138
  • [43] Quality of life improvement as measured by EQ-5D is consistent with clinical response in moderate to severe plaque psoriasis patients treated with adalimumab
    Melilli, LE
    Shikiar, R
    Thompson, C
    VALUE IN HEALTH, 2005, 8 (06) : A147 - A147
  • [44] Effectiveness of adalimumab in the treatment of scalp and nail affection in patients with moderate to severe plaque psoriasis in routine clinical practice
    Bohinc, Masa
    Branisteanu, Daciana Elena
    Khobzey, Kuzma
    Kingo, Kulli
    Pavlovsky, Lev
    Pec, Juraj
    Szegedi, Andrea
    Miljkovic, Jovan
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S33 - S33
  • [45] Minimum clinically important difference in Dermatology Life Quality index in moderate to severe plaque psoriasis patients treated with adalimumab
    Melilli, L
    Shikiar, R
    Thompson, C
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB221 - AB221
  • [46] Effectiveness and security of secukinumab in patients with moderate to severe psoriasis in real clinical practice in a tertiary referral hospital
    Arteaga-Henriquez, Maria
    Lukoviek-Araya, Vania
    Maria Ramirez-Conchas, Jose
    Markthaler, Marcella
    Perez-Robayna, Nuria
    de-Andres-del-Rosario, Ana
    Guimera-Martin-Neda, Francisco
    Garcia-Bustinduy, Marta
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB51 - AB51
  • [47] Secukinumab efficacy and safety in subjects with moderate to severe plaque psoriasis: Results from the Judging the efficacy of secUkinumab in patients with psoriasis using autoiNjector: a Clinical Trial evalUating treatment REsults trial (JUNCTURE)
    Blauvelt, Andrew
    Gottlieb, Alice
    Prinz, Jorg
    Pathan, Rashidkhan
    Cooper, Simon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB185 - AB185
  • [48] Secukinumab Treatment of moderate to severe Plaque Psoriasis in clinical routine care: Data from the PROSPECT Study on the Accompanying Medication at Initiation of Secukinumab Therapy
    Thaci, D.
    Kraehn-Senftleben, G.
    von Kiedrowski, R.
    Behnke, N.
    Ostendorf, R.
    Bachhuber, T.
    Kasparek, T. R.
    Amon, U.
    Augustin, M.
    Körber, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 139 - 139
  • [49] Secukinumab versus ustekinumab for skin clearance in patients with moderate to severe psoriasis after a year of treatment: Real-world practice
    Lopez Jimenez, Patricio
    Suarez Perez, Jorge
    Herrera Acosta, Enrique
    Aguilera Arjona, Jose
    Mendiola Fernandez, Maria V.
    Bosch Garcia, Ricardo
    Herrera Ceballos, Enrique
    DERMATOLOGIC THERAPY, 2019, 32 (04)
  • [50] Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study
    Koerber, A.
    Thaci, D.
    von Kiedrowski, R.
    Bachhuber, T.
    Melzer, N.
    Kasparek, T.
    Kraehn-Senftleben, G.
    Amon, U.
    Augustin, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 411 - 419
12345